These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12919753)

  • 21. Identification of HLA-DRB1*1501-restricted T-cell epitopes from prostate-specific antigen.
    Klyushnenkova EN; Link J; Oberle WT; Kodak J; Rich C; Vandenbark AA; Alexander RB
    Clin Cancer Res; 2005 Apr; 11(8):2853-61. PubMed ID: 15837732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
    Klyushnenkova EN; Kouiavskaia DV; Kodak JA; Vandenbark AA; Alexander RB
    Prostate; 2007 Jul; 67(10):1019-28. PubMed ID: 17455230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Simple Proteomics-Based Approach to Identification of Immunodominant Antigens from a Complex Pathogen: Application to the CD4 T Cell Response against Human Herpesvirus 6B.
    Becerra-Artiles A; Dominguez-Amorocho O; Stern LJ; Calvo-Calle JM
    PLoS One; 2015; 10(11):e0142871. PubMed ID: 26599878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms.
    Fujita H; Senju S; Yokomizo H; Saya H; Ogawa M; Matsushita S; Nishimura Y
    Eur J Immunol; 1998 Jan; 28(1):305-16. PubMed ID: 9485210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
    Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
    Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of the HLA-DRB1*13 allele on measles vaccine response.
    Hayney MS; Poland GA; Jacobson RM; Schaid DJ; Lipsky JJ
    J Investig Med; 1996 Jun; 44(5):261-3. PubMed ID: 8763977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
    Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles-specific T cell clones derived from a twin with multiple sclerosis: genetic restriction studies.
    Richert JR; McFarland HF; McFarlin DE; Johnson AH; Woody JN; Hartzman RJ
    J Immunol; 1985 Mar; 134(3):1561-6. PubMed ID: 2578511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein.
    Muller CP; Ammerlaan W; Fleckenstein B; Krauss S; Kalbacher H; Schneider F; Jung G; Wiesmüller KH
    Int Immunol; 1996 Apr; 8(4):445-56. PubMed ID: 8671631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients.
    Mizote Y; Taniguchi T; Tanaka K; Isobe M; Wada H; Saika T; Kita S; Koide Y; Uenaka A; Nakayama E
    Vaccine; 2010 Jul; 28(32):5338-46. PubMed ID: 20665979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of naturally processed peptides eluted from HLA DRB1*0402 and *0404.
    Hayden JB; McCormack AL; Yates JR; Davey MP
    J Neurosci Res; 1996 Sep; 45(6):795-802. PubMed ID: 8892091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
    Bioley G; Jandus C; Tuyaerts S; Rimoldi D; Kwok WW; Speiser DE; Tiercy JM; Thielemans K; Cerottini JC; Romero P
    J Immunol; 2006 Nov; 177(10):6769-79. PubMed ID: 17082590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation.
    Faner R; James E; Huston L; Pujol-Borrel R; Kwok WW; Juan M
    Eur J Immunol; 2010 Jan; 40(1):91-102. PubMed ID: 19830726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
    Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
    Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
    Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
    J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.
    Wicker LS; Chen SL; Nepom GT; Elliott JF; Freed DC; Bansal A; Zheng S; Herman A; Lernmark A; Zaller DM; Peterson LB; Rothbard JB; Cummings R; Whiteley PJ
    J Clin Invest; 1996 Dec; 98(11):2597-603. PubMed ID: 8958223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.